smellsofbikes writes "GlaxoSmithKline, the world's second-largest pharmaceutical company, is putting thousands of possible malaria-treating drugs into the public domain in a move that the Wall Street Journal calls a 'Linux approach' to pharmaceutical screening. Andrew Witty, who is described as the boss of GSK, says the company thinks it is 'imperative to earn the trust of society, not just by meeting expectations but by exceeding them.' Of course, synthesis or discovery of new chemicals is cheap compared to efficacy and qualification studies, but this is a refreshing change from not handing out any information until after everything is patented."
DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Also, Slashdot's Facebook page has a chat bot now. Message it for stories and more. Check out the new SourceForge HTML5 internet speed test! ×